Advances in imaging technology are transforming the risk assessment, diagnosis and management of cardiac artery disease.
Presenters will discuss the practical applications of these modalities, referencing the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Chest Pain, and expand into diagnosis for other conditions and future research with both modalities. The program’s presenters have been at the forefront of early and ongoing research to develop detection methods for cardiac disease using these imaging modalities.
Advances in imaging technology are transforming the risk assessment, diagnosis and management of cardiac artery disease. This event highlights the role of coronary CT and cardiac MR in detecting abnormalities in the heart chambers, irregularities in blood flow, and arterial blockages – issues often requiring invasive testing for diagnosis.
Presenters will discuss the practical applications of these modalities, referencing the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Chest Pain, and expand into diagnosis for other conditions and future research with both modalities. The program’s presenters have been at the forefront of early and ongoing research to develop detection methods for cardiac disease using these imaging modalities.
- Advancements in cardiac imaging technologies [specific to CCTA and CMR], their emerging role in cardiovascular care and their impact on our comprehension of underlying heart disease mechanisms.
- The impact of CCTA and CMR on diagnosis and treatment stratification.
- Imaging sensitivities through case studies with various scenarios.
- Ongoing research and its potential impacts on the future of cardiovascular care.